Ignite Creation Date:
2024-05-06 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03665545
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-12-27
First Post:
2018-09-01
Brief Title:
Pembrolizumab in Association With the IMA950Poly-ICLC for Relapsing Glioblastoma
Sponsor:
Organization:
University Hospital Geneva